Beauty is doing the heavy lifting at Procter & Gamble right now, and the gap between its strongest and weakest segments is wide enough to raise questions about where the company’s investment dollars are actually going. Third-quarter results for fiscal 2026 confirmed what category watchers have suspected: premium personal care is outpacing household staples, and P&G is leaning into that gap.
Net sales for the January to March quarter rose 7 per cent year-on-year to US$21.2 billion, beating analyst consensus of US$20.5 billion. Organic sales — which strip out foreign exchange movements and the effects of acquisitions and divestitures — grew 3 per cent, with volume contributing 2 percentage points and pricing adding 1 point.
What Is Organic Sales Growth and Why FMCG Professionals Track It
Net sales figures can flatter or obscure the real picture when currency swings and portfolio changes are in the mix. Organic sales growth is the number that brand managers and buyers use to assess genuine demand momentum — it reflects what consumers are actually choosing off the shelf, not what accounting adjustments have added to the top line.
For a company the size of P&G, with operations across more than 180 countries, the organic figure is the one that signals whether core brands are holding their ground or losing it. A 3 per cent organic gain in a quarter marked by geopolitical disruption and cost pressure is a credible result, not a spectacular one — but it is directionally positive.
Beauty Leads, Grooming Trails: The Segment Breakdown
The beauty segment posted organic sales growth of 7 per cent, driven by volume gains of 5 per cent across hair care, skin care, and personal care. Brands including Pantene, Head & Shoulders, and Olay contributed to the result, with hair care performing particularly well in European markets and Greater China recording 3 per cent organic growth.
The remaining segments were more measured. Grooming organic sales rose 1 per cent. Health care grew 2 per cent. Fabric and home care, along with baby, feminine and family care, each posted 3 per cent organic growth — in line with the company average but well behind beauty’s pace.
| Segment | Organic Sales Growth (Q3 FY2026) | Key Driver |
|---|---|---|
| Beauty | +7% | Hair care, skin care, personal care volume |
| Fabric & Home Care | +3% | In line with company average |
| Baby, Feminine & Family Care | +3% | Diapers and family care demand |
| Health Care | +2% | Steady category demand |
| Grooming | +1% | Modest volume recovery |
On the bottom line, operating income remained flat quarter-on-quarter, while net earnings improved 4 per cent. Adjusted earnings per share came in at US$1.59, ahead of the US$1.56 analyst expectation.
What These Results Do Not Resolve
Flat operating income alongside rising net sales points to cost pressure that volume growth is not yet fully absorbing. P&G has flagged approximately US$1 billion in headwinds linked to the Middle East conflict, including higher crude oil prices that flow directly into packaging and raw material costs. That figure has not been offset in this quarter’s result.
Full-year guidance remains in place — net sales growth of 1 to 5 per cent, with organic sales flat to up 4 per cent — but the range is wide enough to accommodate a meaningful deterioration in the second half. For suppliers and co-manufacturers in P&G’s orbit, that uncertainty is worth monitoring closely.
Geographic Performance and What It Signals for Market Strategy
North America organic sales rose 4 per cent, with volume up 3 percentage points — the strongest regional result. Europe grew 2 per cent, led by a 6 per cent increase in enterprise markets. Greater China posted 3 per cent organic growth, a notable recovery for a market that has been a persistent drag on P&G’s results in recent years.
CEO Shailesh Jejurikar described the quarter as a “solid acceleration in top-line results” with “broad-based growth across product categories and regions.” He confirmed the company is increasing investment to sustain consumer momentum despite what he called a “challenging geopolitical and economic environment.”
That investment signal matters for the Australian market. P&G’s local portfolio spans Pantene, Head & Shoulders, Olay, Gillette, Oral-B, and Pampers — brands with significant shelf presence across Coles, Woolworths, and Chemist Warehouse. When the global parent signals increased marketing spend, Australian category managers can reasonably expect above-the-line activity to follow in the back half of the calendar year.
Beauty’s Outperformance Reflects a Broader FMCG Shift
P&G’s beauty result is not an isolated data point. Across the global FMCG landscape, premium personal care has consistently outpaced household staples as consumers demonstrate a willingness to trade up on products they apply to their bodies while trading down on cleaning and laundry. Private label has made inroads in fabric care and paper products, but branded beauty — particularly hair care with proven efficacy claims — has held its price premium more effectively.
For Australian retailers and brand managers, the implication is structural. Category investment in beauty is likely to intensify as global FMCG majors chase the segment where volume and pricing power are both moving in the right direction at the same time.
If P&G’s beauty momentum holds through the fourth quarter, the pressure on competing brands to match its investment levels on Australian shelves will only increase.